Management of sleep disorders in Parkinson's disease and multiple system atrophy
- 24 January 2017
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 32 (5) , 659-668
Abstract
Parkinson's disease (PD) and multiple system atrophy (MSA) are disorders associated with α synuclein‐related neurodegeneration. Nonmotor symptoms are common hallmarks of these disorders, and disturbances of the sleep–wake cycle are among the most common nonmotor symptoms. It is only recently that sleep disturbances have received the attention of the medical and research community. Significant progress has been made in understanding the pathophysiology of sleep and wake disruption in alphasynucleinopathies during the past few decades. Despite these advancements, treatment options are limited and frequently associated with problematic side effects. Further studies that center on the development of novel treatment approaches are very much needed. In this article, the author discusses the current state of the management of disturbed sleep and alertness in PD and MSA. © 2017 International Parkinson and Movement Disorder SocietyKeywords
Funding Information
- National Institutes of Health (K23 NS072283)
This publication has 107 references indexed in Scilit:
- Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson’s diseaseParkinsonism & Related Disorders, 2012
- Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohortSleep Medicine, 2011
- The effects of deep brain stimulation on sleep in Parkinson’s diseaseTherapeutic Advances in Neurological Disorders, 2010
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)Movement Disorders, 2010
- Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placeboMovement Disorders, 2010
- Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseNeurology, 2010
- Melatonin and Bright‐Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer's DiseaseJournal of the American Geriatrics Society, 2008
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030Neurology, 2007
- A community‐based study of sleep disorders in patients with Parkinson's diseaseMovement Disorders, 1998
- Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorderNeurology, 1996